Elif Hindie

Bordeaux, 33000, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 175 publications

Introduction to special issue - Primary hyperparathyroidism.

Introduction to special issue - Primary hyperparathyroidism.

Journal: Journal of visceral surgery

Published: August 11, 2026

Terbium-161 might be superior to lutetium-177 for oligometastases.

Terbium-161 might be superior to lutetium-177 for oligometastases.

Journal: The Lancet. Oncology

Published: May 25, 2026

Prospective study on the [18F]FDOPA PET/CT role in the management of medullary thyroid cancer patients with high residual calcitonin level after surgery.

Prospective study on the [18F]FDOPA PET/CT role in the management of medullary thyroid cancer patients with high residual calcitonin level after surgery.

Journal: European journal of nuclear medicine and molecular imaging

Published: February 06, 2026

Prospective head-to-head comparison of [68Ga]Ga-RM2 PET/CT and [68Ga]Ga-PSMA-617 PET/CT in newly diagnosed patients with intermediate-risk localized prostate cancer.

Prospective head-to-head comparison of [68Ga]Ga-RM2 PET/CT and [68Ga]Ga-PSMA-617 PET/CT in newly diagnosed patients with intermediate-risk localized prostate cancer.

Journal: European journal of nuclear medicine and molecular imaging

Published: December 22, 2025

Prognostic impact of Dmax on baseline FDG-PET/CT in newly diagnosed multiple myeloma.

Prognostic impact of Dmax on baseline FDG-PET/CT in newly diagnosed multiple myeloma.

Journal: Haematologica

Published: November 13, 2025

[177Lu]Lu-dota-tate versus sunitinib in patients with metastatic progressive neuroendocrine tumours of the pancreas (OCLURANDOM): a randomised, controlled, phase 2 trial.

[177Lu]Lu-dota-tate versus sunitinib in patients with metastatic progressive neuroendocrine tumours of the pancreas (OCLURANDOM): a randomised, controlled, phase 2 trial.

Journal: The Lancet. Oncology

Published: November 04, 2025

French expert consensus statement on diagnosis and management of primary hyperparathyroidism.

French expert consensus statement on diagnosis and management of primary hyperparathyroidism.

Journal: Annales d'endocrinologie

Published: September 01, 2025

GRPR Expression in Metastatic Cancers: A Review of Potential Application of GRPR-Radioligand Therapy.

GRPR Expression in Metastatic Cancers: A Review of Potential Application of GRPR-Radioligand Therapy.

Journal: Seminars in nuclear medicine

Published: June 28, 2025

[18F]-Labeled Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in Staging and Restaging Patients With Breast Cancer.

[18F]-Labeled Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in Staging and Restaging Patients With Breast Cancer.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: March 25, 2025

N-Terminal Stabilization of Radiolabeled Neurotensin Analogues for Improved Tumor Uptake.

N-Terminal Stabilization of Radiolabeled Neurotensin Analogues for Improved Tumor Uptake.

Journal: Journal of medicinal chemistry

Published: March 20, 2025

Synergy Between Radiopharmaceutical Therapy and Immune Response: Deciphering the Underpinning Mechanisms for Future Actions.

Synergy Between Radiopharmaceutical Therapy and Immune Response: Deciphering the Underpinning Mechanisms for Future Actions.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: March 04, 2025

CheckMate 8HW and the future of dual immunotherapy.

CheckMate 8HW and the future of dual immunotherapy.

Journal: Lancet (London, England)

Published: February 15, 2025

Showing 1-12 of 175

Last Updated: 09/26/2026